Latest News about NYSE:JNJ
Recent news which mentions NYSE:JNJ
Supplying an Award-Winning Model for Diversity and Inclusion
January 19, 2022
Catalyst Pharmaceuticals: A Biotech Stock Worth Owning
January 18, 2022
Is electroCore a Good Stock to Add to Your Healthcare Portfolio?
January 14, 2022
How Johnson & Johnson's Innovative Supply Chain Technology is Helping Transform How We Work - and Live
January 13, 2022
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
January 12, 2022
Is Now a Good Time to Scoop Up Shares of Canopy Growth?
January 11, 2022
Healthcare Sector Report for 2022: A Complete Investor's Guide
January 05, 2022
Is Biofrontera a Winner in the Biopharmaceutical Industry?
January 03, 2022
Is Biofrontera a Good Pharmaceuticals Stock to Own?
December 02, 2021
Johnson & Johnson Announces Significant Progress Towards Its Climate Goals - 100% Renewable Electricity for All Sites in the United States, Canada and Europe by 2023
November 30, 2021
Worried About a Crash? Consider Buying These 4 Stocks Right Now
November 29, 2021
Should You Buy the Dip in Tilray?
November 26, 2021
4 ESG Healthcare Stocks to Buy for Socially Conscious Investors
November 16, 2021
JNJ Split: 10 Things for Investors to Know About Johnson & Johnson’s Breakup Plans
November 12, 2021
Is Assertio Holdings a Good Drug Manufacturing Stock to Own?
November 10, 2021
Buy These 4 Healthcare Stocks After Reporting Better Than Expected Earnings Results
October 27, 2021
How to Make $500K Last Forever with Dividends
October 27, 2021
From Contrarian Outlook
Johnson & Johnson Executive Jennifer Taubert Named to 2021 Fortune Most Powerful Women in Business List
October 26, 2021
How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS
October 13, 2021
Does Sonoma Pharmaceuticals Deserve a Place in Your Portfolio?
October 04, 2021
2 Dow Jones Stocks to Buy in October, 2 to Avoid
September 29, 2021
4 No-Brainer Pharmaceutical Stocks to Buy in October
September 27, 2021